The TLR7 agonist, imiquimod, increases IFN-beta production and reduces the severity of experimental autoimmune encephalomyelitis (Q43170477)

From Wikidata
Jump to navigation Jump to search
scientific article published on 6 February 2010
edit
Language Label Description Also known as
English
The TLR7 agonist, imiquimod, increases IFN-beta production and reduces the severity of experimental autoimmune encephalomyelitis
scientific article published on 6 February 2010

    Statements

    The TLR7 agonist, imiquimod, increases IFN-beta production and reduces the severity of experimental autoimmune encephalomyelitis (English)
    Kate O'Brien
    Denise Fitzgerald
    Abdolmohamad Rostami
    6 February 2010
    107-111

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit